Attached files

file filename
EX-10.23 - EX-10.23 - Axogen, Inc.axgn-20161231ex1023b18e9.htm
EX-32.1 - EX-32.1 - Axogen, Inc.axgn-20161231ex32171e006.htm
EX-31.2 - EX-31.2 - Axogen, Inc.axgn-20161231ex3128616d2.htm
EX-31.1 - EX-31.1 - Axogen, Inc.axgn-20161231ex311b6f48c.htm
EX-21.1 - EX-21.1 - Axogen, Inc.axgn-20161231ex21184e732.htm
EX-10.24 - EX-10.24 - Axogen, Inc.axgn-20161231ex10240391a.htm
EX-10.22 - EX-10.22 - Axogen, Inc.axgn-20161231ex102219b9a.htm
EX-10.21 - EX-10.21 - Axogen, Inc.axgn-20161231ex1021432c1.htm
EX-10.20 - EX-10.20 - Axogen, Inc.axgn-20161231ex1020ff12e.htm
EX-10.10.2 - EX-10.10.2 - Axogen, Inc.axgn-20161231ex101028e10.htm
10-K - 10-K - Axogen, Inc.axgn-20161231x10k.htm

EXHIBIT 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statements of AxoGen, Inc. on Form S-3 (File Nos. 333-207829 and 333-195588) and Form S-8 (File Nos. 333-211660, 333-201238 and 333-177980) of our report dated March 1, 2017, appearing in this annual report on form 10-K of AxoGen, Inc. and Subsidiaries as of and for the years ended December 31, 2016 and 2015.

 

 

/s/ LURIE, LLP

 

 

Minneapolis, Minnesota

March 1, 2017